Physician profile
Julia Dancyger
NPI 1457086340
$1,007.02
in general payments reported to CMS, 2019-2025
18 companies · $61.80 in 2025
The $61.80 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $119 · 2023: $808 · 2024: $18.12 · 2025: $61.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $282.99 | 2022-2025 | |
| Glaxosmithkline, LLC. | $132.60 | 2023 | Trelegy Ellipta, Shingrix |
| Otsuka America Pharmaceutical, INC. | $108.31 | 2022-2023 | Nuedexta, Rexulti |
| Lilly USA, LLC | $86.50 | 2022-2023 | Emgality, Jardiance, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $55.04 | 2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.28 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $40.30 | 2023 | Quviviq |
| Viiv Healthcare Company | $30.36 | 2023 | Apretude |
| Currax Pharmaceuticals LLC | $29.82 | 2023 | Contrave, Onzetra Xsail |
| Bayer Healthcare Pharmaceuticals INC. | $28.56 | 2023 | |
| Axsome Therapeutics, INC. | $26.68 | 2023 | Sunosi |
| Lundbeck LLC | $26.36 | 2023 | Rexulti |
| Alkermes, INC. | $24.85 | 2023 | Vivitrol |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.81 | 2022 | |
| Supernus Pharmaceuticals, INC. | $20.23 | 2023 | Qelbree |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18.33 | 2023 | Pneumovax 23, Gardasil 9, Vaxneuvance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.03 | 2023 | Xifaxan |
| Exact Sciences Corporation | $14.97 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Dancyger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.